Apixaget (Apixaban) is indicated for:
• The prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery.
• The prevention of stroke and systemic embolism in patients with atrial fibrillation.
• The treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention of recurrent DVT and PE.